GlobalView

Lamb, David S.

Statistics
Title Hits Visitors Downloads
A methodology for the analysis of PSA response signatures 44 43 0
A randomized controlled trial of an exercise intervention targeting cardiovascular and metabolic risk factors for prostate cancer patients from the RADAR trial 176 169 0
Risk stratification after biochemical failure following curative treatment of locally advanced prostate cancer: data from the TROG 96.01 trial 18 13 0
Radiation dose escalation or longer androgen suppression for locally advanced prostate cancer? Data from the TROG 03.04 RADAR trial 9 7 0
A multicentre year-long randomised controlled trial of exercise training targeting physical functioning in men with prostate cancer previously treated with androgen suppression and radiation from TROG 03.04 RADAR 28 26 0
Survival benefit confirmed for prostate cancers diagnosed by PSA testing (letter) 71 66 0
Paradoxical metastatic progression following 3 months of neo-adjuvant androgen suppression in the TROG 96.01 trial for men with locally advanced prostate cancer 35 30 0
PSA response signatures: a powerful new prognostic indicator after radiation for prostate cancer? 125 117 0
A comparison of the prognostic value of early PSA test-based variables following external beam radiotherapy, with or without preceding androgen deprivation: analysis of data from the TROG 96.01 randomized trial 24 19 0
Short-term neoadjuvant androgen deprivation and radiotherapy for locally advanced prostate cancer: 10-year data from the TROG 96.01 randomised trial 29 27 0
Rectal and urinary dysfunction in the TROG 03.04 RADAR trial for locally advanced prostate cancer 17 14 0
Time to biochemical failure and prostate-specific antigen doubling time as surrogates for prostate cancer-specific mortality: evidence from the TROG 96.01 randomised controlled trial 127 116 0
Recognizing false biochemical failure calls after radiation with or without neo-adjuvant androgen deprivation for prostate cancer 140 132 0
Why are pretreatment prostate-specific antigen levels and biochemical recurrence poor predictors of prostate cancer survival? 137 129 0
Measuring time to biochemical failure in the Trog 96.01 trial: when should the clock start ticking? 147 142 0
Quality of life in men with locally advanced prostate cancer treated with leuprorelin and radiotherapy with or without zoledronic acid (TROG 03.04 RADAR): secondary endpoints from a randomised phase 3 factorial trial 6 5 0
Repository Search URL

Lamb, David S.

Formatted Bibliography URL

Lamb, David S.

Bibliography Markup

To include a live feed of this author's bibliography on a static Web page (e.g., a personal home page), add the following HTML code to the body of your HTML.